» Articles » PMID: 25686090

Multidrug Resistance Transporters Snq2p and Pdr5p Mediate Caffeine Efflux in Saccharomyces Cerevisiae

Overview
Date 2015 Feb 17
PMID 25686090
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

SNQ2 was identified as a caffeine-resistance gene by screening a genomic library of Saccharomyces cerevisiae in a multicopy vector YEp24. SNQ2 encodes an ATP-binding cassette transporter and is highly homologous to PDR5. Multicopy of PDR5 also conferred resistance to caffeine, while its resistance was smaller than that of SNQ2. Residual caffeine contents were analyzed after transiently exposing cells to caffeine. The ratios of caffeine contents were 21.3 ± 8.8% (YEp24-SNQ2) and 81.9 ± 8.7% (YEp24-PDR5) relative to control (YEp24, 100%). In addition, multicopies of SNQ2 or PDR5 conferred resistance to rhodamine 6G (R6G), which was widely used as a substrate for transport assay. R6G was exported by both transporters, and their efflux activities were inhibited by caffeine with half-maximal inhibitory concentrations of 5.3 ± 1.9 (YEp24-SNQ2) and 17.2 ± 9.6 mM (YEp24-PDR5). These results demonstrate that Snq2p is a more functional transporter of caffeine than Pdr5p in yeast cells.

Citing Articles

An mTOR inhibitor discovery system using drug-sensitized yeast.

Breen A, Thomas S, Beckett D, Agsalud M, Gingras G, Williams J Geroscience. 2025; .

PMID: 39885115 DOI: 10.1007/s11357-025-01534-8.


Experimental evolution of Saccharomyces cerevisiae for caffeine tolerance alters multidrug resistance and target of rapamycin signaling pathways.

Geck R, Moresi N, Anderson L, Brewer R, Renz T, Taylor M G3 (Bethesda). 2024; 14(9).

PMID: 38989875 PMC: 11373655. DOI: 10.1093/g3journal/jkae148.


Transportation engineering for enhanced production of plant natural products in microbial cell factories.

Zuo Y, Zhao M, Gou Y, Huang L, Xu Z, Lian J Synth Syst Biotechnol. 2024; 9(4):742-751.

PMID: 38974023 PMC: 11224930. DOI: 10.1016/j.synbio.2024.05.014.


Experimental evolution of for caffeine tolerance alters multidrug resistance and TOR signaling pathways.

Geck R, Moresi N, Anderson L, Brewer R, Renz T, Taylor M bioRxiv. 2024; .

PMID: 38746122 PMC: 11092465. DOI: 10.1101/2024.04.28.591555.


Acquired Triazole Resistance Alters Pathogenicity-Associated Features in in an Isolate-Dependent Manner.

Bohner F, Papp C, Takacs T, Varga M, Szekeres A, Nosanchuk J J Fungi (Basel). 2023; 9(12).

PMID: 38132749 PMC: 10744493. DOI: 10.3390/jof9121148.